1. Copyright © 2006 American Medical Association. All rights reserved.
From: Serum Urea Nitrogen, Creatinine, and Estimators of Renal FunctionMortality in Older Patients With Cardiovascular Disease
Arch Intern Med. 2006;166(10): doi: /archinte
Figure Legend:
Mortality curves for 5th to 95th percentile values of serum urea nitrogen (SUN) level (A and B), creatinine level (C and D), Modification of Diet in Renal Disease (MDRD) estimated glomerular filtration rate (eGFR) (E and F), and Mayo eGFR in patients who experienced a myocardial infarction (A, C, E, and G) and heart failure (B, D, F, and H). To convert SUN to millimoles per liter, multiply by 0.357; and to convert creatinine to micromoles per liter, multiply by 88.4.
Date of download: 10/29/2017
Copyright © 2006 American Medical Association. All rights reserved.

2. Copyright © 2006 American Medical Association. All rights reserved.
From: Serum Urea Nitrogen, Creatinine, and Estimators of Renal FunctionMortality in Older Patients With Cardiovascular Disease
Arch Intern Med. 2006;166(10): doi: /archinte
Figure Legend:
Relative prognostic importance of serum urea nitrogen (SUN) level, creatinine level, Modification of Diet in Renal Disease estimated glomerular filtration rate (MDRD eGFR), Mayo eGFR and other risk factors as indicated by percentage of explained variance of mortality risks in patients who experienced a myocardial infarction (MI) (A) and heart failure (HF) (B). The asterisk indicates that there was an improvement in explained variance (R2) compared with a model without the predictor of interest, relative to the explained variance for the full model with all the covariates (actual value for the MI group, R2 = 0.25; and for the HF group, R2 = 0.20). These models were adjusted for age, sex, race, comorbidities, medications, and hospital characteristics. All variables were significant predictors of mortality at P<.001, except for prior MI (P<.05). The dagger indicates this was an alternative model using Mayo eGFR instead of MDRD eGFR. ACEI indicates angiotensin-converting enzyme inhibitor; and LVSF, left ventricular systolic function.
Date of download: 10/29/2017
Copyright © 2006 American Medical Association. All rights reserved.